Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC). Azenosertib is being evaluated as a monotherapy and in combination across multiple tumor types in clinical trials and has broad franchise potential. In clinical trials, azenosertib has been well tolerated and has demonstrated anti-tumor activity as a single agent across multiple tumor types. The Company is also leveraging its extensive experience and capabilities to translate its science to advance research on additional areas of opportunity for azenosertib outside PROC. The Associate Director, Quality Control, is responsible for overseeing all quality control activities performed at external laboratories in support of the Company’s small-molecule, solid oral dosage development program. This individual will manage outsourced testing operations, ensure the accuracy and integrity of analytical data, lead QC-related investigations, and oversee the Company’s stability program. The position will work closely with Quality Assurance, Analytical Development, and external partners to support phase-appropriate analytical controls and readiness for commercial operations. This is an individual-contributor leadership role with significant cross-functional interaction and high visibility within the organization.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
101-250 employees